A topically applied anaesthetic preparation which would render painless procedures such as venepuncture would be of considerable value in paediatric practice. To produce analgesia, the local anaesthetic must penetrate the skin barrier (stratum corneum) to reach the underlying pain receptors (nociceptors). It is now agreed generally that an ideal formulation should provide rapid, deep and relatively long-lasting anaesthesia of both the skin surface and the underlying tissues [1] [2] [3] [4] . To these requirements should be added the proviso that an effective preparation must contain the minimum concentration of local anaesthetic consistent with producing the desired clinical effect.
Currently, only one such preparation (EMLA cream) is available commercially. This requires a minimum onset time for anaesthesia of 1 h, with approximately 2.5 g of the cream being applied under occlusion to a venepuncture site. Recently, a comparative assessment, both in vivo and in vitro, of the percutaneous absorption of a range of local anaesthetic agents identified amethocaine as significantly better than lignocaine at producing full-depth anaesthesia to the challenge of insertion of a sterile needle [5] . The present study reports a concentration-response in vivo assessment of three percutaneous anaesthetic formulations based on amethocaine in order to identify the minimum concentration of the drug required for effective percutaneous local anaesthesia.
SUBJECTS, MATERIALS AND METHODS

Chemicals
Amethocaine base U.S.P. was obtained from Ward Blenkinsop Ltd, Cheshire, U.K. Methylcellulose (viscosity 400 centipoise at 20 °C, 2 % aqueous solution) was obtained from Sigma Ltd, Poole, U.K. and Carbomer 934P from B. F. Goodrich Ltd, Cleveland, U.S.A. All other materials used were of pharmacopoeial quality.
Formulations
Three formulations were used: A and B were aqueous gels based, respectively, on carbomer (1.5 % w/w) and methylcellulose (7 % w/w), each containing various concentrations of amethocaine. Formulation C was an oil-in-water cream formed from Emulsifying Wax B.P. (16% w/w), liquid paraffin (4 % w/w) and water, and again containing various concentrations of local anaesthetic drug. All formulations were prepared by conventional pharmaceutical techniques.
Volunteer studies
Twenty healthy adult volunteers (nine male), aged 18-37 yr were studied. Each volunteer gave informed written consent and the study was approved by the local Ethics Committee. Each volunteer received all formulations, including a placebo formulation (Avicel incorporated in the appropriate base). Formulations were allocated to volunteers on a random basis. Volunteers were not told which formulation they had received. Both left and right forearms (ventral surface at or just below the anterior cubital fossa) were used and a minimum period of 7 days was maintained between successive trials on previously treated individuals.
Each formulation (0.5 g) was applied to the test site and covered with a dressing (Op-Site I. V., Smith and Nephew Ltd, Hull, U.K.) for 30 min. The formulation was then removed, the site swabbed with 70% alcohol and the treated area delineated with an indelible marker. Anaesthesia was determined by the pin-prick method described previously [5] . Onset of anaesthesia was assessed on initial removal of the formulation, and at 5-min intervals thereafter. Assessment was discontinued if anaesthesia was not apparent 90 min after initial application of the formulation. When anaesthesia was apparent, the duration of the effect was ( assessed by the pin-prick method at 15-min intervals. In this study, volunteers were asked to distinguish between full anaesthesia (coded 1) and no or only partial anaesthesia (coded 0). Volunteers were given appropriate training before the trial and 12 of the volunteers had participated in a previous study on percutaneous local anaesthesia [5] .
Statistical analysis
Within each formulation, results were analysed in terms of time required for full onset of anaesthesia (determined from initial application time of the formulation) and duration of the full anaesthetic effect. Results were analysed only from those formulations which achieved a success rate of at least 90%. Statistical analysis of these results was made using single factor analysis of variance (ANOVA) with repeated measurements [6] . Specific comparisons of formulations within each analysis group were made using the Newman-Keuls multiple range test [7] . In both cases, the significance of difference was taken to be P < 0.01. Formulations were designated according to the formulation type (A, B or C) and the amethocaine concentration (% w/w).
RESULTS
Formulations A and B were prepared with anaesthetic concentrations from 0 (placebo) to 5 % w/w, whereas series C required a higher concentration range for efficacy (8-14% w/w). Results recorded for each volunteer were efficacy (1, 0), onset time (min) and duration of full anaesthesia (h) (table I). All volunteers had no effect from placebo with any formulation. For formulation A, lower drug concentrations proved unreliable in producing anaesthesia. Thus 1 % amethocaine gave anaesthesia in only 45% of volunteers, increasing to 75% on doubling the concentration. Efficacy increased to 90% with 3 % anaesthetic and to 95 % beyond this concentration. A similar pattern was apparent in formulation B. For formulation C, 8% amethocaine anaesthetized the skin of only 30 % of volunteers, increasing to 90% with 10% anaesthetic and 95 % for 12 % and 14 % drug concentrations. One volunteer claimed to be unresponsive to all formulations, perhaps emphasizing the subjective nature of pain assessment. All three formulations showed a tendency to shorter onset times and longer duration of anaesthesia with increased drug concentration. Results were analysed in detail for those formulations with a percentage efficacy > 90 % by single factor ANOVA. It was apparent that, within each formulation, the most effective preparations (A3-A5, B3-B5, C10-C14) were not equivalent. Specific comparisons of formulations by the Newman-Keuls multiple range test demonstrated that formulations A4 and A5 were equivalent in terms of onset time, as were B4 and B5, and C12 and C14. ANOVA on A4, B4 and C12 indicated that there was no significant difference (P < 0.01) between these three formulations with respect to onset time for anaesthesia.
The most effective within each formulation were analysed by ANOVA with respect to duration of anaesthesia. Again, formulations were non-equivalent within each series. Specific comparisons by the Newman-Keuls test showed that no two formulations within a given series were equivalent in terms of duration of effect and that, between formulations, only A4 and B4 were not significantly different. Formulations A4, B4 and C12, which were not significantly different in terms of onset time, were not equivalent in terms of duration of anaesthesia.
DISCUSSION
To formulate an acceptable percutaneous local anaesthetic preparation, one must use a low anaesthetic concentration and exclude all penetration enhancing agents [5] . The choice of vehicle must be such that, although the drug concentration remains acceptably low, the concentration gradient across the skin barrier is maximized. The present study assessed three formulation series in terms of a concentration-response analysis. Often, in previous studies scant attention has been paid to the choice of vehicle. Thus a standard oilin-water cream was used as the basis of one formulation (C) and was compared with aqueous gel formulations prepared from carbomer (A) and methylcellulose (B). Two different gelling agents were used to demonstrate that the hydrophilic nature of the formulation was important, rather than the specific polymer used.
An effective percutaneous anaesthetic may produce profound anaesthesia of the skin surface and underlying tissues, sufficient even to allow the pain-free cutting of split skin grafts [8] . Although there are many methods of experimental pain induction, it is now well recognized that pricking of the skin by a sterile needle is an excellent indicator of full-depth percutaneous anaesthesia [9] [10] [11] . Results are coherent if a pattern is set in the test area and the skin punctured a fixed number of times. Experience in our laboratory has shown that a pattern of six pin-pricks constitutes a sufficient pain stimulus and that volunteers should be trained to recognize the distinctive nature of percutaneous anaesthesia before entering the trial. The ease of testing therefore makes in vivo studies the approach of choice for formulation development and results are, therefore, of immediate clinical significance. Thus 20 volunteers were used to assess the efficacy of each formulation with respect to differing anaesthetic concentrations. Only full-depth anaesthesia was regarded as effective. Partial anaesthesia was regarded as a failure and the test was thus a stringent one. Both the time of onset, measured from initial application, and duration of anaesthesia were considered. Of these observations, onset time can be considered the more important. Onset times of greater than 1 h are unacceptable from the viewpoint of ward routine. Duration of anaesthesia should be sufficient to allow the required procedure to take place within normal ward routine and to provide some degree of pain control after the procedure. In our experience, a minimum period of 2 h is required. Thus onset and duration of anaesthesia have been analysed separately.
A number of conclusions can be made from this study. Clearly, a suitable formulation must contain a sufficient concentration of anaesthetic to promote penetration of the skin barrier and overcome the individual variations in skin type and condition, which can vary even on a day-today basis for an individual. However, it is not possible to reduce onset time by increasing the drug concentration. Thus 4% anaesthetic provided the fastest onset of anaesthesia consistent with the requirement for the lowest anaesthetic concentration in both formulation A and B. Onset times for A4 and B4 were 40.3 (6.3) and 41.8 (5.8) min, respectively. For formulation C, however, it was necessary to use an anaesthetic concentration of 12 % to produce an equivalent result. Unlike A and B, which were completely aqueous systems, C contained approximately 20% of lipid phase. This may compete with the stratum corneum, itself lipophilic in character, for the lipophilic anaesthetic base, and therefore a higher concentration of anaesthetic is necessary than when a hydrophilic system is used. Providing that there is no polymer-drug interaction, either chemical or physical, the equivalence of A4 and B4 demonstrates that the particular hydrophilic polymer used is unimportant. The effect of an increased lipid phase in the formulation goes some way to explaining the previously observed superiority of amethocaine as a percutaneous anaesthetic over other agents [5] . Amethocaine is considerably more lipophilic, for example, than lignocaine [12] . Duration of anaesthesia can be increased to some extent by increasing the concentration of anaesthetic agent (table I) . However, A4, B4 and C12 all produced effective anaesthesia of the site for approximately 3 h, and this is certainly sufficient in practice. The fact that anaesthesia begins after the preparation is removed from the site indicates that penetration of the stratum corneum by the anaesthetic is the rate-limiting factor. Therefore, anaesthesia of the underlying tissues follows release of drug from the barrier. Higher concentrations of anaesthetic allow more drug to enter the barrier and increase the duration of anaesthesia. This results also when increased contact times between skin and formulation are used, the limiting point being reached when the stratum corneum is saturated effectively with drug. However, experience in our laboratory has shown that a 30-min contact time is sufficient to produce the desired clinical requirements in terms of efficacy, onset time and duration of anaesthesia.
This study has demonstrated that hydrophilic formulations of amethocaine produce effective, reliable and rapid anaesthesia of the skin sufficient to allow minor procedures such as venepuncture to proceed painlessly. Prolonged anaesthesia can be obtained with acceptably low concentrations of amethocaine in the hydrophilic vehicle.
